| Balance Sheet for Keryx Biopharmaceuticals Inc. (KERX) | | | | | | | Assets | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Cash and Equivalents | 19,065 | 48,736 | 68,175 | 29,699 | 21,672 | | Marketable Securities | 43,038 | 63,659 | 18,272 | 20,035 | 9,631 | | Receivables | 283 | 2,573 | 3,536 | 766 | 676 | | Inventories | - | - | - | - | - | | Other Current Assets | 1,330 | - | - | - | - | | Total Current Assets | 63,716 | 114,968 | 89,983 | 50,500 | 31,979 | | | Gross Fixed Assets | 11,985 | 8,845 | 1,221 | 262 | 74 | | Accumulated Depreciation | (488) | (356) | (217) | (117) | (50) | | Net Fixed Assets | 11,497 | 8,489 | 1,004 | 145 | 24 | | Intangibles | - | 614 | - | 132 | 1,007 | | Other Non-Current Assets | 2,640 | 13,034 | 14,110 | 85 | (787) | | Total Non-Current Assets | 17,345 | 25,345 | 15,114 | 362 | 244 | | Total Assets | 81,061 | 140,313 | 105,097 | 50,862 | 32,223 | | | Liabilities | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Accounts Payable | 19,134 | 10,460 | 5,054 | 3,079 | 894 | | Short Term Debt | - | - | - | - | - | | Other Current Liabilities | - | - | - | - | - | | Total Current Liabilities | 21,411 | 12,194 | 6,093 | 3,962 | 997 | | | Long Term Debt | - | - | - | - | - | | Deferred Income Tax | - | - | - | - | - | | Other Non-Current Liabilities | 15,228 | 4,298 | 4,326 | 4,096 | - | | Minority Interest | - | - | - | - | - | | Total Non-Current Liabilities | 15,228 | 4,298 | 4,326 | 4,096 | - | | Total Liabilities | 36,639 | 16,492 | 10,419 | 8,058 | 997 | | | Preferred Stock Equity | - | - | - | - | - | | Common Stock Equity | 44,422 | 123,821 | 94,678 | 42,804 | 31,226 | | Total Equity | 44,422 | 123,821 | 94,678 | 42,804 | 31,226 | | Total Liabilities & Stock Equity | 81,061 | 140,313 | 105,097 | 50,862 | 32,223 | | | |
